These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Multiple ramp domains are required for generation of amylin receptor phenotype from the calcitonin receptor gene product. Zumpe ET, Tilakaratne N, Fraser NJ, Christopoulos G, Foord SM, Sexton PM. Biochem Biophys Res Commun; 2000 Jan 07; 267(1):368-72. PubMed ID: 10623626 [Abstract] [Full Text] [Related]
9. Specificity of porcine calcitonin receptor and calcitonin receptor-like receptor in the presence of receptor-activity-modifying proteins. Kikumoto K, Katafuchi T, Minamino N. Hypertens Res; 2003 Feb 07; 26 Suppl():S15-23. PubMed ID: 12630807 [Abstract] [Full Text] [Related]
10. Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins. Moad HE, Pioszak AA. Protein Sci; 2013 Dec 07; 22(12):1775-85. PubMed ID: 24115156 [Abstract] [Full Text] [Related]
11. Structural Basis for Receptor Activity-Modifying Protein-Dependent Selective Peptide Recognition by a G Protein-Coupled Receptor. Booe JM, Walker CS, Barwell J, Kuteyi G, Simms J, Jamaluddin MA, Warner ML, Bill RM, Harris PW, Brimble MA, Poyner DR, Hay DL, Pioszak AA. Mol Cell; 2015 Jun 18; 58(6):1040-52. PubMed ID: 25982113 [Abstract] [Full Text] [Related]
12. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function. Qi T, Christopoulos G, Bailey RJ, Christopoulos A, Sexton PM, Hay DL. Mol Pharmacol; 2008 Oct 18; 74(4):1059-71. PubMed ID: 18593822 [Abstract] [Full Text] [Related]
14. Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice. Pawlak JB, Wetzel-Strong SE, Dunn MK, Caron KM. Peptides; 2017 Feb 18; 88():1-7. PubMed ID: 27940069 [Abstract] [Full Text] [Related]
15. Functional relevance of G-protein-coupled-receptor-associated proteins, exemplified by receptor-activity-modifying proteins (RAMPs). Fischer JA, Muff R, Born W. Biochem Soc Trans; 2002 Aug 18; 30(4):455-60. PubMed ID: 12196114 [Abstract] [Full Text] [Related]
16. Expression of the CGRP Family of Neuropeptides and their Receptors in the Trigeminal Ganglion. Edvinsson L, Grell AS, Warfvinge K. J Mol Neurosci; 2020 Jun 18; 70(6):930-944. PubMed ID: 32086679 [Abstract] [Full Text] [Related]
17. Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25. Hay DL, Garelja ML, Poyner DR, Walker CS. Br J Pharmacol; 2018 Jan 18; 175(1):3-17. PubMed ID: 29059473 [Abstract] [Full Text] [Related]
18. Evidence for Conservation of the Calcitonin Superfamily and Activity-regulating Mechanisms in the Basal Chordate Branchiostoma floridae: INSIGHTS INTO THE MOLECULAR AND FUNCTIONAL EVOLUTION IN CHORDATES. Sekiguchi T, Kuwasako K, Ogasawara M, Takahashi H, Matsubara S, Osugi T, Muramatsu I, Sasayama Y, Suzuki N, Satake H. J Biol Chem; 2016 Jan 29; 291(5):2345-56. PubMed ID: 26644465 [Abstract] [Full Text] [Related]
19. Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat. Oliver KR, Kane SA, Salvatore CA, Mallee JJ, Kinsey AM, Koblan KS, Keyvan-Fouladi N, Heavens RP, Wainwright A, Jacobson M, Dickerson IM, Hill RG. Eur J Neurosci; 2001 Aug 29; 14(4):618-28. PubMed ID: 11556887 [Abstract] [Full Text] [Related]
20. Type II Turn of Receptor-bound Salmon Calcitonin Revealed by X-ray Crystallography. Johansson E, Hansen JL, Hansen AM, Shaw AC, Becker P, Schäffer L, Reedtz-Runge S. J Biol Chem; 2016 Jun 24; 291(26):13689-98. PubMed ID: 27189946 [Abstract] [Full Text] [Related] Page: [Next] [New Search]